REDWOOD CITY, Calif.--(BUSINESS WIRE)--Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health") or (the "Company") today announced that it has entered into a strategic partnership with Theranostics Laboratory, a translational research company, with offices in the USA and New Zealand. Theranostics laboratory was founded at the Cleveland Clinic in 2010 and works on subcontracted research, in collaboration with the Auckland Bioengineering Institute (ABI), in New Zealand, and with NASA (via NASA Grant NCC 9-58).
The Auckland Bioengineering Institute is recognised as a world-leader in the field of personalised modelling and is part of the international Virtual Physiologic Human (VPH) project (http://physiomeproject.org/). The Institute has successfully commercialised numerous mHealth technologies, including wireless telemetry systems, wearable sensors and a needle-free injectable system into the US market.
Help employers find you! Check out all the jobs and post your resume.
The Auckland Bioengineering Institute is recognised as a world-leader in the field of personalised modelling and is part of the international Virtual Physiologic Human (VPH) project (http://physiomeproject.org/). The Institute has successfully commercialised numerous mHealth technologies, including wireless telemetry systems, wearable sensors and a needle-free injectable system into the US market.
Help employers find you! Check out all the jobs and post your resume.
